Neuronal calcium signaling: Function and dysfunction

Cellular and Molecular Life Sciences

Volumn 71, Issue 15, 2014, Pages 2787-2814

  Brini, Marisa ^a   Calì, Tito ^a   Ottolini, Denis ^a   Carafoli, Ernesto ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Calcium channels; Calcium pumps; Calcium signaling; Migraine; Neurodegenerative disorders; Neurons

Indexed keywords

AMYLOID BETA PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; LEVODOPA; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; SODIUM CHANNEL NAV1.1;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM BINDING; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CEREBELLAR ATAXIA; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; FAMILIAL HEMIPLEGIC MIGRAINE; GENE CONTROL; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LONG TERM POTENTIATION; MISSENSE MUTATION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; REVIEW; SYNAPTIC TRANSMISSION;

EUKARYOTA;

ANIMALS; BRAIN; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 84904396432     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1550-7     Document Type: Review

References (247)

1. Carafoli E, Malmstrom K, Sigel E, Crompton M (1976) The regulation of intracellular calcium. Clin Endocrinol (Oxf) 5[Suppl]:49S-59S
2. Brini M, Cali T, Ottolini D, Carafoli E (2013) Intracellular calcium homeostasis and signaling. Met Ions Life Sci 12:119-168. doi:10.1007/978-94-007- 5561-1-5
3. Mellstrom B, Savignac M, Gomez-Villafuertes R, Naranjo JR (2008) Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev 88(2):421-449. doi:10.1152/physrev.00041.2005 (Pubitemid 351520085)
4. Carafoli E (2007) The unusual history and unique properties of the calcium signal. In: Krebs J, Michalak M (eds) Calcium: a matter of life and death, vol 41. Elsevier, Amsterdam, pp 3-22
5. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG (2006) Orai1 is an essential pore subunit of the CRAC channel. Nature 443(7108):230-233. doi:10.1038/nature05122 (Pubitemid 44387613)
6. Hofmann F, Lacinova L, Klugbauer N (1999) Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 139:33-87
7. Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521-555. doi:10.1146/annurev.cellbio.16.1. 521
8. Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (2007) Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 28(5):220-228. doi:10.1016/j.tips.2007.03.005 (Pubitemid 46661004)
9. Hoppa MB, Lana B, Margas W, Dolphin AC, Ryan TA (2012) Alpha2delta expression sets presynaptic calcium channel abundance and release probability. Nature 486(7401):122-125. doi:10.1038/nature11033
10. Catterall WA (2011) Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3(8):a003947. doi:10.1101/cshperspect.a003947
11. Miyashita T, Oda Y, Horiuchi J, Yin JC, Morimoto T, Saitoe M (2012) Mg(2+) block of Drosophila NMDA receptors is required for long-term memory formation and CREB-dependent gene expression. Neuron 74(5):887-898. doi:10.1016/j.neuron.2012.03.039
12. Rosenmund C, Stern-Bach Y, Stevens CF (1998) The tetrameric structure of a glutamate receptor channel. Science 280(5369):1596-1599 (Pubitemid 28277703)
13. Greger IH, Khatri L, Kong X, Ziff EB (2003) AMPA receptor tetramerization is mediated by Q/R editing. Neuron 40(4):763-774 (Pubitemid 37431036)
14. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406(6791):78-81. doi:10.1038/35017558 (Pubitemid 30460214)
15. Bowie D, Mayer ML (1995) Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyam-ine- mediated ion channel block. Neuron 15(2):453-462
16. Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383-400. doi:10.1038/nrn3504
17. Hardingham GE, Chawla S, Cruzalegui FH, Bading H (1999) Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron 22(4):789-798 (Pubitemid 29203501)
18. Hardingham GE, Arnold FJ, Bading H (2001) Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 4(3):261-267. doi:10.1038/85109 (Pubitemid 32194873)
19. Hardingham GE, Arnold FJ, Bading H (2001) A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci 4(6):565-566. doi:10.1038/88380 (Pubitemid 32507368)
20. Impey S, Goodman RH (2001) CREB signaling - timing is everything. Sci STKE 2001(82):pe1. doi:10.1126/stke.2001.82.pe1
21. Wu GY, Deisseroth K, Tsien RW (2001) Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 98(5):2808-2813. doi:10.1073/pnas.051634198 (Pubitemid 32209565)
22. Barco A, Alarcon JM, Kandel ER (2002) Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 108(5):689-703 (Pubitemid 34245387)
23. Corlew R, Brasier DJ, Feldman DE, Philpot BD (2008) Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist 14(6):609-625. doi:10.1177/1073858408322675
24. Burnstock G, Di Virgilio F (2013) Purinergic signalling and cancer. Purinergic Signal. doi:10.1007/s11302-013-9372-5
25. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32(2):79-87. doi:10.1016/j. tins.2008.11.003
26. Franke H, Verkhratsky A, Burnstock G, Illes P (2012) Pathophysiology of astroglial purinergic signalling. Purinergic Signal 8(3):629-657. doi:10.1007/s11302-012-9300-0
27. Levano-Garcia J, Dluzewski AR, Markus RP, Garcia CR (2010) Purinergic signalling is involved in the malaria parasite Plasmodium falciparum invasion to red blood cells. Purinergic Signal 6(4):365-372. doi:10.1007/s11302-010-9202-y
28. Pankratov Y, Lalo U, Krishtal OA, Verkhratsky A (2009) P2X receptors and synaptic plasticity. Neuroscience 158(1):137- 148. doi:10.1016/j.neuroscience. 2008.03.076
29. Hamilton NB, Attwell D (2010) Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11(4):227-238. doi:10.1038/nrn2803
30. Burnstock G, Verkhratsky A (2010) Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1:e9. doi:10.1038/cddis.2009.11
31. Zimmermann H (2011) Purinergic signaling in neural development. Semin Cell Dev Biol 22(2):194-204. doi:10.1016/j.semcdb.2011.02.007
32. Browne LE, Jiang LH, North RA (2010) New structure enlivens interest in P2X receptors. Trends Pharmacol Sci 31(5):229-237. doi:10.1016/j.tips.2010.02. 004
33. Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31-304. doi:10.1016/S0074-7696(04)40002-3 (Pubitemid 39539202)
34. Pankratov Y, Lalo U, Krishtal O, Verkhratsky A (2003) P2X receptor-mediated excitatory synaptic currents in somatosensory cortex. Mol Cell Neurosci 24(3):842-849 (Pubitemid 37506024)
35. Duan S, Neary JT (2006) P2X(7) receptors: properties and relevance to CNS function. Glia 54(7):738-746. doi:10.1002/glia.20397 (Pubitemid 44629636)
36. Putney JW Jr (1986) A model for receptor-regulated calcium entry. Cell Calcium 7(1):1-12
37. Feske S (2011) Immunodeficiency due to defects in store-operated calcium entry. Ann N Y Acad Sci 1238:74-90. doi:10.1111/j.1749-6632.2011.06240.x
38. Putney JW (2012) Calcium signaling: deciphering the calcium- NFAT pathway. Curr Biol 22(3):R87-R89. doi:10.1016/j.cub.2011.12.030
39. Gwack Y, Srikanth S, Feske S, Cruz-Guilloty F, Oh-hora M, Neems DS, Hogan PG, Rao A (2007) Biochemical and functional characterization of Orai proteins. J Biol Chem 282(22):16232-16243. doi:10.1074/jbc.M609630200 (Pubitemid 47100386)
40. Venkiteswaran G, Hasan G (2009) Intracellular Ca2+ signaling and store-operated Ca2+ entry are required in Drosophila neurons for flight. Proc Natl Acad Sci USA 106(25):10326-10331. doi:10.1073/pnas.0902982106
41. Berna-Erro A, Braun A, Kraft R, Kleinschnitz C, Schuhmann MK, Stegner D, Wultsch T, Eilers J, Meuth SG, Stoll G, Nieswandt B (2009) STIM2 regulates capacitive Ca2+ entry in neurons and plays a key role in hypoxic neuronal cell death. Sci Signal 2(93):ra67. doi:10.1126/scisignal.2000522
42. Thompson JL, Mignen O, Shuttleworth TJ (2013) The ARC channel - an endogenous store-independent Orai channel. Curr Top Membr 71:125-148. doi:10.1016/ B978-0-12-407870-3.00006-8
43. Rohacs T (2007) Regulation of TRP channels by PIP(2). Pflugers Arch 453(6):753-762. doi:10.1007/s00424-006-0153-7
44. Ambudkar IS, Ong HL, Liu X, Bandyopadhyay BC, Cheng KT (2007) TRPC1: the link between functionally distinct store-operated calcium channels. Cell Calcium 42(2):213-223. doi:10.1016/j.ceca.2007.01.013 (Pubitemid 47039032)
45. Lu M, Branstrom R, Berglund E, Hoog A, Bjorklund P, Westin G, Larsson C, Farnebo LO, Forsberg L (2010) Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid. J Mol Endocrinol 44(5):285-294. doi:10.1677/ JME-09-0138
46. Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L (2007) Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 104(11):4682-4687. doi:10.1073/pnas. 0611692104 (Pubitemid 47186285)
47. Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX (2009) The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels. Pflugers Arch 458(5):869-876. doi:10.1007/s00424-009-0682-y
48. Wang X, Zhang X, Dong XP, Samie M, Li X, Cheng X, Goschka A, Shen D, Zhou Y, Harlow J, Zhu MX, Clapham DE, Ren D, Xu H (2012) TPC proteins are phosphoinositide-activated sodium-selective ion channels in endosomes and lysosomes. Cell 151(2):372-383. doi:10.1016/j.cell.2012.08.036
49. Brini M, Carafoli E (2011) The plasma membrane Ca(2)+ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol 3(2). doi:10.1101/cshperspect.a004168
50. Blaustein MP, Juhaszova M, Golovina VA, Church PJ, Stanley EF (2002) Na/Ca exchanger and PMCA localization in neurons and astrocytes: functional implications. Ann N Y Acad Sci 976:356-366 (Pubitemid 36126917)
51. Blaustein MP, Golovina VA (2001) Structural complexity and functional diversity of endoplasmic reticulum Ca(2+) stores. Trends Neurosci 24(10):602-608 (Pubitemid 32913391)
52. Bano D, Young KW, Guerin CJ, Lefeuvre R, Rothwell NJ, Naldini L, Rizzuto R, Carafoli E, Nicotera P (2005) Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120(2):275-285. doi:10.1016/j.cell.2004.11.049 (Pubitemid 40174769)
53. Annunziato L, Pignataro G, Boscia F, Sirabella R, Formisano L, Saggese M, Cuomo O, Gala R, Secondo A, Viggiano D, Molinaro P, Valsecchi V, Tortiglione A, Adornetto A, Scorziello A, Cataldi M, Di Renzo GF (2007) ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia. Ann N Y Acad Sci 1099:413-426. doi:10.1196/annals.1387.050 (Pubitemid 47092613)
54. James P, Maeda M, Fischer R, Verma AK, Krebs J, Penniston JT, Carafoli E (1988) Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem 263(6):2905-2910 (Pubitemid 18062943)
55. Enyedi A, Verma AK, Heim R, Adamo HP, Filoteo AG, Strehler E, Penniston JT (1994) The Ca2+ affinity of the plasma membrane Ca2+ pump is controlled by alternative splicing. J Biol Chem 269(1):41-43
56. .Falchetto R, Vorherr T, Brunner J, Carafoli E (1991) The plasma membrane Ca2+ pump contains a site that interacts with its calmodulin-binding domain. J Biol Chem 266(5):2930-2936 (Pubitemid 21909157)
57. Falchetto R, Vorherr T, Carafoli E (1992) The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme. Protein Sci 1(12):1613-1621. doi:10.1002/pro.5560011209 (Pubitemid 23047477)
58. Enyedi A, Vorherr T, James P, McCormick DJ, Filoteo AG, Carafoli E, Penniston JT (1989) The calmodulin binding domain of the plasma membrane Ca2+ pump interacts both with calmodulin and with another part of the pump. J Biol Chem 264(21):12313-12321 (Pubitemid 19191119)
59. Zvaritch E, James P, Vorherr T, Falchetto R, Modyanov N, Carafoli E (1990) Mapping of functional domains in the plasma membrane Ca2+ pump using trypsin proteolysis. Biochemistry 29(35):8070-8076 (Pubitemid 20283291)
60. Brodin P, Falchetto R, Vorherr T, Carafoli E (1992) Identification of two domains which mediate the binding of activating phospholipids to the plasma-membrane Ca2+ pump. Eur J Biochem 204(2):939-946
61. Oceandy D, Cartwright EJ, Emerson M, Prehar S, Baudoin FM, Zi M, Alatwi N, Venetucci L, Schuh K, Williams JC, Armesilla AL, Neyses L (2007) Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation 115(4):483-492. doi:10.1161/CIRCULATIONAHA.106. 643791 (Pubitemid 46184200)
62. Mohamed TM, Oceandy D, Zi M, Prehar S, Alatwi N, Wang Y, Shaheen MA, Abou-Leisa R, Schelcher C, Hegab Z, Baudoin F, Emerson M, Mamas M, Di Benedetto G, Zaccolo M, Lei M, Cartwright EJ, Neyses L (2011) Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. J Biol Chem 286(48):41520-41529. doi:10.1074/jbc.M111.290411
63. Ficarella R, Di Leva F, Bortolozzi M, Ortolano S, Donaudy F, Petrillo M, Melchionda S, Lelli A, Domi T, Fedrizzi L, Lim D, Shull GE, Gasparini P, Brini M, Mammano F, Carafoli E (2007) A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. Proc Natl Acad Sci USA 104(5):1516-1521. doi:10.1073/pnas.0609775104 (Pubitemid 46214622)
64. Spiden SL, Bortolozzi M, Di Leva F, de Angelis MH, Fuchs H, Lim D, Ortolano S, Ingham NJ, Brini M, Carafoli E, Mammano F, Steel KP (2008) The novel mouse mutation Oblivion inactivates the PMCA2 pump and causes progressive hearing loss. PLoS Genet 4(10):e1000238. doi:10.1371/ journal.pgen.1000238
65. Street VA, McKee-Johnson JW, Fonseca RC, Tempel BL, Noben-Trauth K (1998) Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat Genet 19(4):390-394 (Pubitemid 28357914)
66. Bortolozzi M, Brini M, Parkinson N, Crispino G, Scimemi P, De Siati RD, Di Leva F, Parker A, Ortolano S, Arslan E, Brown SD, Carafoli E, Mammano F (2010) The novel PMCA2 pump mutation Tommy impairs cytosolic calcium clearance in hair cells and links to deafness in mice. J Biol Chem 285(48):37693-37703. doi:10.1074/jbc.M110.170092
67. Takahashi K, Kitamura K (1999) A point mutation in a plasma membrane Ca(2+)-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem Biophys Res Commun 261(3):773-778 (Pubitemid 29408132)
68. Schultz JM, Yang Y, Caride AJ, Filoteo AG, Penheiter AR, Lagziel A, Morell RJ, Mohiddin SA, Fananapazir L, Madeo AC, Penniston JT, Griffith AJ (2005) Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med 352(15):1557-1564 (Pubitemid 40517096)
69. Zanni G, Cali T, Kalscheuer VM, Ottolini D, Barresi S, Lebrun N, Montecchi-Palazzi L, Hu H, Chelly J, Bertini E, Brini M, Carafoli E (2012) Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+ homeostasis. Proc Natl Acad Sci USA 109(36):14514-14519. doi:10.1073/pnas.1207488109
70. Taylor CW, Tovey SC (2010) IP(3) receptors: toward understanding their activation. Cold Spring Harb Perspect Biol 2(12):a004010. doi:10.1101/ cshperspect.a004010
71. Taylor CW, Laude AJ (2002) IP3 receptors and their regulation by calmodulin and cytosolic Ca2+. Cell Calcium 32(5-6):321-334 (Pubitemid 36175753)
72. Lanner JT, Georgiou DK, Joshi AD, Hamilton SL (2010) Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol 2(11):a003996. doi:10.1101/cshperspect.a003996
73. De Flora A, Franco L, Guida L, Bruzzone S, Zocchi E (1998) Ectocellular CD38-catalyzed synthesis and intracellular Ca(2+)-mobilizing activity of cyclic ADP-ribose. Cell Biochem Biophys 28(1):45-62. doi:10.1007/BF02738309 (Pubitemid 128532708)
74. Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89(4):1341-1378. doi:10.1152/phys rev.00032.2008
75. Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R (1999) Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci USA 96(24):13807-13812
76. Denton RM (2009) Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta 1787(11):1309- 1316. doi:10.1016/j.bbabio.2009.01.005
77. Hajnoczky G, Robb-Gaspers LD, Seitz MB, Thomas AP (1995) Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82(3):415-424
78. Hajnoczky G, Hager R, Thomas AP (1999) Mitochondria suppress local feedback activation of inositol 1,4, 5-trisphosphate receptors by Ca2+. J Biol Chem 274(20):14157-14162
79. Hoth M, Fanger CM, Lewis RS (1997) Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J Cell Biol 137(3):633-648 (Pubitemid 27200666)
80. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher- Timme CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, Koteliansky V, Mootha VK (2011) Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476(7360):341-345. doi:10.1038/nature10234
81. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476(7360):336-340. doi:10.1038/nature10230
82. Raffaello A, De Stefani D, Sabbadin D, Teardo E, Merli G, Picard A, Checchetto V, Moro S, Szabo I, Rizzuto R (2013) The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit. EMBO J 32(17):2362-2376. doi:10.1038/emboj.2013.157
83. Csordas G, Golenar T, Seifert EL, Kamer KJ, Sancak Y, Perocchi F, Moffat C, Weaver D, de la Fuente Perez S, Bogorad R, Koteliansky V, Adijanto J, Mootha VK, Hajnoczky G (2013) MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca(2)(+) uniporter. Cell Metab 17(6):976-987. doi:10.1016/j.cmet.2013.04.020
84. Mallilankaraman K, Doonan P, Cardenas C, Chandramoorthy HC, Muller M, Miller R, Hoffman NE, Gandhirajan RK, Molgo J, Birnbaum MJ, Rothberg BS, Mak DO, Foskett JK, Madesh M (2012) MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival. Cell 151(3):630-644. doi:10.1016/j.cell.2012.10.011
85. Plovanich M, Bogorad RL, Sancak Y, Kamer KJ, Strittmatter L, Li AA, Girgis HS, Kuchimanchi S, De Groot J, Speciner L, Taneja N, Oshea J, Koteliansky V, Mootha VK (2013) MICU2, a paralog of MICU1, resides within the mitochondrial uniporter complex to regulate calcium handling. PLoS One 8(2):e55785. doi:10.1371/journal.pone.0055785
86. Sancak Y, Markhard AL, Kitami T, Kovacs-Bogdan E, Kamer KJ, Udeshi ND, Carr SA, Chaudhuri D, Clapham DE, Li AA, Calvo SE, Goldberger O, Mootha VK (2013) EMRE is an essential component of the mitochondrial calcium uniporter complex. Science 342:1379-1382. doi:10.1126/science.1242993
87. Carafoli E, Tiozzo R, Lugli G, Crovetti F, Kratzing C (1974) The release of calcium from heart mitochondria by sodium. J Mol Cell Cardiol 6(4):361-371
88. Palty R, Silverman WF, Hershfinkel M, Caporale T, Sensi SL, Parnis J, Nolte C, Fishman D, Shoshan-Barmatz V, Herrmann S, Khananshvili D, Sekler I (2010) NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci USA 107(1):436-441. doi:10.1073/pnas.0908099107
89. Bernardi P, von Stockum S (2012) The permeability transition pore as a Ca(2+) release channel: new answers to an old question. Cell Calcium 52(1):22-27. doi:10.1016/j.ceca.2012.03.004
90. Bernardi P (2013) The mitochondrial permeability transition pore: a mystery solved? Front Physiol 4:95. doi:10.3389/fp hys.2013.00095
91. Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P (2013) Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12(4):674-683. doi:10.4161/ cc.23599
92. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabo I, Lippe G, Bernardi P (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 110(15):5887-5892. doi:10.1073/pnas.1217823110
93. Chin D, Means AR (2000) Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10(8):322-328 (Pubitemid 30445239)
94. Catterall WA, Few AP (2008) Calcium channel regulation and presynaptic plasticity. Neuron 59(6):882-901. doi:10.1016/j. neuron.2008.09.005
95. Schwaller B (2009) The continuing disappearance of "pure"Ca2+ buffers. Cell Mol Life Sci 66(2):275-300. doi:10.1007/s00018-008-8564-6
96. Schmidt H, Eilers J (2009) Spine neck geometry determines spino-dendritic cross-talk in the presence of mobile endogenous calcium binding proteins. J Comput Neurosci 27(2):229-243. doi:10.1007/s10827-009-0139-5
97. Schmidt H, Kunerth S, Wilms C, Strotmann R, Eilers J (2007) Spino-dendritic cross-talk in rodent Purkinje neurons mediated by endogenous Ca2+-binding proteins. J Physiol 581(Pt 2):619-629. doi:10.1113/jphysiol.2007. 127860 (Pubitemid 46831760)
98. Fierro L, Llano I (1996) High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. J Physiol 496(Pt 3):617-625 (Pubitemid 26387847)
99. Schwaller B, Tetko IV, Tandon P, Silveira DC, Vreugdenhil M, Henzi T, Potier MC, Celio MR, Villa AE (2004) Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol Cell Neurosci 25(4):650-663. doi:10.1016/j.mcn.2003.12.006 (Pubitemid 38481474)
100. Gall D, Roussel C, Susa I, D'Angelo E, Rossi P, Bearzatto B, Galas MC, Blum D, Schurmans S, Schiffmann SN (2003) Altered neuronal excitability in cerebellar granule cells of mice lacking calretinin. J Neurosci 23(28):9320-9327 (Pubitemid 37323031)
101. Moreno H, Burghardt NS, Vela-Duarte D, Masciotti J, Hua F, Fenton AA, Schwaller B, Small SA (2012) The absence of the calcium-buffering protein calbindin is associated with faster age-related decline in hippocampal metabolism. Hippocampus 22(5):1107-1120. doi:10.1002/hipo.20957
102. Pongs O, Lindemeier J, Zhu XR, Theil T, Engelkamp D, Krah- Jentgens I, Lambrecht HG, Koch KW, Schwemer J, Rivosecchi R et al (1993) Frequenin-a novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. Neuron 11(1):15-28 (Pubitemid 23222530)
103. McFerran BW, Graham ME, Burgoyne RD (1998) Neuronal Ca2+ sensor 1, the mammalian homologue of frequenin, is expressed in chromaffin and PC12 cells and regulates neurosecretion from dense-core granules. J Biol Chem 273(35):22768-22772 (Pubitemid 28399850)
104. McFerran BW, Weiss JL, Burgoyne RD (1999) Neuronal Ca(2+) sensor 1. Characterization of the myristoylated protein, its cellular effects in permeabilized adrenal chromaffin cells, Ca(2+)-independent membrane association, and interaction with binding proteins, suggesting a role in rapid Ca(2+) signal transduction. J Biol Chem 274(42):30258-30265
105. Weiss JL, Archer DA, Burgoyne RD (2000) Neuronal Ca2+ sensor-1/frequenin functions in an autocrine pathway regulating Ca2+ channels in bovine adrenal chromaffin cells. J Biol Chem 275(51):40082-40087. doi:10.1074/jbc.M008603200 (Pubitemid 32064633)
106. Tsujimoto T, Jeromin A, Saitoh N, Roder JC, Takahashi T (2002) Neuronal calcium sensor 1 and activity-dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals. Science 295(5563):2276-2279. doi:10.1126/ science.1068278
107. Sippy T, Cruz-Martin A, Jeromin A, Schweizer FE (2003) Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1. Nat Neurosci 6(10):1031-1038. doi:10.1038/nn1117 (Pubitemid 37186194)
108. Jo J, Heon S, Kim MJ, Son GH, Park Y, Henley JM, Weiss JL, Sheng M, Collingridge GL, Cho K (2008) Metabotropic glutamate receptor-mediated LTD involves two interacting Ca(2+) sensors, NCS-1 and PICK1. Neuron 60(6):1095-1111. doi:10.1016/j.neuron.2008.10.050
109. Dason JS, Romero-Pozuelo J, Marin L, Iyengar BG, Klose MK, Ferrus A, Atwood HL (2009) Frequenin/NCS-1 and the Ca2+- channel alpha1-subunit co-regulate synaptic transmission and nerve-terminal growth. J Cell Sci 122(Pt 22):4109-4121. doi:10.1242/jcs.055095
110. Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA (1999) Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399(6732):155-159. doi:10.1038/20194
111. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ (2000) Modulation of A-type potassium channels by a family of calcium sensors. Nature 403(6769):553-556. doi:10.1038/35000592 (Pubitemid 30082201)
112. Carrion AM, Link WA, Ledo F, Mellstrom B, Naranjo JR (1999) DREAM is a Ca2+-regulated transcriptional repressor. Nature 398(6722):80-84. doi:10.1038/18044
113. Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, Wasco W (1998) Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med 4(10):1177-1181. doi:10.1038/2673 (Pubitemid 28468832)
114. De Strooper B, Iwatsubo T, Wolfe MS (2012) Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med 2(1):a006304. doi:10.1101/cshperspect.a006304
115. Gomez-Villafuertes R, Torres B, Barrio J, Savignac M, Gabellini N, Rizzato F, Pintado B, Gutierrez-Adan A, Mellstrom B, Carafoli E, Naranjo JR (2005) Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons. J Neurosci 25(47):10822-10830. doi:10.1 523/JNEUROSCI.3912-05.2005
116. Ronkainen JJ, Hanninen SL, Korhonen T, Koivumaki JT, Skoumal R, Rautio S, Ronkainen VP, Tavi P (2011) Ca2+-calmod-ulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation. J Physiol 589(Pt 11):2669- 2686. doi:10.1113/jphysiol.2010.201400
117. Fontan-Lozano A, Romero-Granados R, del-Pozo-Martin Y, Suarez-Pereira I, Delgado-Garcia JM, Penninger JM, Carrion AM (2009) Lack of DREAM protein enhances learning and memory and slows brain aging. Curr Biol 19(1):54-60. doi:10.1016/j.cub.2008.11.056
118. Alexander JC, McDermott CM, Tunur T, Rands V, Stelly C, Karhson D, Bowlby MR, An WF, Sweatt JD, Schrader LA (2009) The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning. Learn Mem 16(3):167-177. doi:10.1101/ lm.1261709
119. Wu LJ, Mellstrom B, Wang H, Ren M, Domingo S, Kim SS, Li XY, Chen T, Naranjo JR, Zhuo M (2010) DREAM (downstream regulatory element antagonist modulator) contributes to synaptic depression and contextual fear memory. Mol Brain 3:3. doi:10.1186/1756-6606-3-3
120. Zhang Y, Su P, Liang P, Liu T, Liu X, Liu XY, Zhang B, Han T, Zhu YB, Yin DM, Li J, Zhou Z, Wang KW, Wang Y (2010) The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit. J Neurosci 30(22):7575-7586. doi:10.1523/JNEUROSCI.1312-10.2010
121. Rivera-Arconada I, Benedet T, Roza C, Torres B, Barrio J, Krzyzanowska A, Avendano C, Mellstrom B, Lopez-Garcia JA, Naranjo JR (2010) DREAM regulates BDNF-dependent spinal sensitization. Mol Pain 6:95. doi:10.1186/1744- 8069-6-95
122. Karp G (2002) Cell and molecular biology. Wiley, New York
123. Hudmon A, Schulman H (2002) Neuronal CA2+/calmodulindependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473-510. doi:10.1146/annurev.biochem.71.110601.135410 (Pubitemid 34800228)
124. Bading H (2013) Nuclear calcium signalling in the regulation of brain function. Nat Rev Neurosci 14(9):593-608. doi:10.1038/nrn3531
125. Dick O, Bading H (2010) Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death sig-nal- associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors. J Biol Chem 285(25):19354-19361. doi:10.1074/jbc.M110.127654
126. Foskett JK (2010) Inositol trisphosphate receptor Ca2+ release channels in neurological diseases. Pflugers Arch 460(2):481- 494. doi:10.1007/s00424-010- 0826-0
127. Camandola S, Mattson MP (2011) Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta 1813(5):965-973. doi:10.1016/j.bbamcr.2010.10.005
128. Duchen MR (2012) Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Arch 464(1):111-121. doi:10.1007/s00424-012- 1112-0
129. Cali T, Ottolini D, Brini M (2012) Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium 52(1):73-85. doi:10.1016/j. ceca.2012.04.015
130. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59-62. doi:10.1038/362059a0 (Pubitemid 23087289)
131. Carriedo SG, Yin HZ, Weiss JH (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16(13):4069-4079 (Pubitemid 26192403)
132. Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688-1700. doi:10.1056/N EJM200105313442207
133. von Lewinski F, Keller BU (2005) Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci 28(9):494-500. doi:10.1016/j.tins.2005.07.001
134. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36(6):846-858. doi:10.1002/ana. 410360608 (Pubitemid 24370923)
135. Iacopino AM, Christakos S (1990) Corticosterone regulates calbindin-D28k mRNA and protein levels in rat hippocampus. J Biol Chem 265(18):10177-10180
136. Beers DR, Ho BK, Siklos L, Alexianu ME, Mosier DR, Mohamed AH, Otsuka Y, Kozovska ME, McAlhany RE, Smith RG, Appel SH (2001) Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem 79(3):499-509 (Pubitemid 33029923)
137. Bernard-Marissal N, Moumen A, Sunyach C, Pellegrino C, Dudley K, Henderson CE, Raoul C, Pettmann B (2012) Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS. J Neurosci 32(14):4901-4912. doi:10.1523/JNEURO SCI.5431-11.2012
138. Beal MF (2000) Mitochondria and the pathogenesis of ALS. Brain 123(Pt 7):1291-1292
139. Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G (2006) Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J Neurochem 96(5):1349-1361. doi:10.1111/j.1471-4159.2006.03619.x
140. Carri MT, Ferri A, Battistoni A, Famhy L, Gabbianelli R, Poccia F, Rotilio G (1997) Expression of a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 414(2):365-368 (Pubitemid 27389396)
141. Ferri A, Cozzolino M, Crosio C, Nencini M, Casciati A, Gralla EB, Rotilio G, Valentine JS, Carri MT (2006) Familial ALSsuperoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci USA 103(37):13860- 13865. doi:10.1073/pnas.0605814103
142. Son M, Leary SC, Romain N, Pierrel F, Winge DR, Haller RG, Elliott JL (2008) Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. J Biol Chem 283(18):12267-12275. doi:10.1074/jbc.M708523200
143. Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ, Manfredi G, Elliott JL (2007) Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci USA 104(14):6072-6077. doi:10.1073/pnas.0610923104 (Pubitemid 47175660)
144. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277(33):29626-29633. doi:10.1074/jbc.M203065200 (Pubitemid 41079252)
145. Jung C, Higgins CM, Xu Z (2002) Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 83(3):535-545 (Pubitemid 35231807)
146. Jaiswal MK, Keller BU (2009) Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Mol Pharmacol 75(3):478-489. doi:10.1124/mol.108.050831
147. Jaiswal MK, Zech WD, Goos M, Leutbecher C, Ferri A, Zippelius A, Carri MT, Nau R, Keller BU (2009) Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci 10:64. doi:10.1186/1471-2202-10-64
148. Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL, Coyle JT (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28(1):18-25. doi:10.1002/ana. 410280106 (Pubitemid 20222147)
149. Carriedo SG, Sensi SL, Yin HZ, Weiss JH (2000) AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20(1):240-250 (Pubitemid 30220511)
150. Takuma H, Kwak S, Yoshizawa T, Kanazawa I (1999) Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol 46(6):806-815
151. Guatteo E, Carunchio I, Pieri M, Albo F, Canu N, Mercuri NB, Zona C (2007) Altered calcium homeostasis in motor neurons following AMPA receptor but not voltagedependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol Dis 28(1):90-100. doi:10.1016/j.nbd. 2007.07.002 (Pubitemid 47429977)
152. Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90(3):905-981. doi:10.1152/phys rev.00041.2009
153. Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, Warby SC, Doty CN, Roy S, Wellington CL, Leavitt BR, Raymond LA, Nicholson DW, Hayden MR (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125(6):1179-1191. doi:10.1016/j. cell.2006.04.026
154. Olzscha H, Schermann SM, Woerner AC, Pinkert S, Hecht MH, Tartaglia GG, Vendruscolo M, Hayer-Hartl M, Hartl FU, Vabulas RM (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144(1):67-78. doi:10.1016/j.cell.2010.11.050
155. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 93(10):5037-5042 (Pubitemid 26163505)
156. Yamanaka T, Nukina N (2010) Transcription factor sequestration by polyglutamine proteins. Methods Mol Biol 648:215- 229. doi:10.1007/978-1-60761- 756-3-14
157. Fan MM, Raymond LA (2007) N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol 81(5-6):272-293. doi:10.1016/j.pneurobio.2006.11.003 (Pubitemid 46528641)
158. Bezprozvanny I (2007) Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease. Subcell Biochem 45:323-335
159. Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 283(9):5780-5789. doi:10.1074/jbc.M704704200
160. Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium-binding pro-tein- containing neurons in Huntington's disease. Lancet 1(8597):1252-1255
161. Dong G, Gross K, Qiao F, Ferguson J, Callegari EA, Rezvani K, Zhang D, Gloeckner CJ, Ueffing M, Wang H (2012) Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity. J Neurochem 123(3):437-446. doi:10.1111/j.1471-4159.2012.07919.x
162. Sun Y, Savanenin A, Reddy PH, Liu YF (2001) Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95. J Biol Chem 276(27):24713-24718. doi:10.1074/jbc. M103501200
163. Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17(4):1652-1663. doi:10.1091/mbc.E05-07-0607 (Pubitemid 44011583)
164. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13(10):4181-4192 (Pubitemid 23299942)
165. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5(8):731-736. doi:10.1038/nn884 (Pubitemid 34827590)
166. Panov AV, Burke JR, Strittmatter WJ, Greenamyre JT (2003) In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Arch Biochem Biophys 410(1):1-6 (Pubitemid 36268790)
167. Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13(14):1407-1420. doi:10.1093/hmg/ddh162 (Pubitemid 39023049)
168. Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, Hayden MR, Bezprozvanny I (2003) Huntingtin and huntingtinassociated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39(2):227-239 (Pubitemid 36897546)
169. Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, Marambaud P (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133(7):1149-1161. doi:10.1016/j.cell.2008.05.048 (Pubitemid 351863682)
170. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31(9):454-463. doi:10.1016/j.tins.2008.06.005
171. Green KN, LaFerla FM (2008) Linking calcium to Abeta and Alzheimer's disease. Neuron 59(2):190-194. doi:10.1016/j.neuron.2008.07.013 (Pubitemid 352033693)
172. Berridge MJ (2010) Calcium hypothesis of Alzheimer's disease. Pflugers Arch 459(3):441-449. doi:10.1007/s00424-009-0736-1
173. Lopez JR, Lyckman A, Oddo S, Laferla FM, Querfurth HW, Shtifman A (2008) Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem 105(1):262-271. doi:10.1111/j.1471-4159.2007.05135.x (Pubitemid 351441642)
174. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59(2):214- 225. doi:10.1016/j.neuron.2008.06.008
175. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457(7233):1128-1132. doi:10.1038/nature07761
176. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12(2):376-389
177. Kawahara M, Kuroda Y (2000) Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull 53(4):389-397 (Pubitemid 32000815)
178. Kagan BL, Hirakura Y, Azimov R, Azimova R, Lin MC (2002) The channel hypothesis of Alzheimer's disease: current status. Peptides 23(7):1311-1315 (Pubitemid 34786709)
179. Price SA, Held B, Pearson HA (1998) Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones. NeuroReport 9(3):539-545 (Pubitemid 28109219)
180. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, De Strooper B, Yu G, Bezprozvanny I (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126(5):981- 993. doi:10.1016/j.cell.2006.06.059
181. Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26(19):5180-5189. doi:10.1523/ JNEUROSCI.0739-06.2006
182. Cheung KH, Shineman D, Muller M, Cardenas C, Mei L, Yang J, Tomita T, Iwatsubo T, Lee VM, Foskett JK (2008) Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58(6):871- 883. doi:10.1016/j.neuron.2008.04.015
183. Brunello L, Zampese E, Florean C, Pozzan T, Pizzo P, Fasolato C (2009) Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake. J Cell Mol Med 13(9B):3358-3369. doi:10.1111/j.1582-4934. 2009.00755.x
184. Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, LaFerla FM (2008) SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Cell Biol 181(7):1107-1116. doi:10.1083/jcb.200706171 (Pubitemid 351915486)
185. Zampese E, Fasolato C, Kipanyula MJ, Bortolozzi M, Pozzan T, Pizzo P (2011) Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. Proc Natl Acad Sci USA 108(7):2777-2782. doi:10.1073/p nas.1100735108
186. Leissring MA, Parker I, LaFerla FM (1999) Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals. J Biol Chem 274(46):32535-32538 (Pubitemid 129535275)
187. Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin GM, Mattson MP (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. NeuroReport 8(1):379-383 (Pubitemid 126785592)
188. Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP (2000) Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 275(24):18195-18200. doi:10.1074/jbc.M000040200 (Pubitemid 30414771)
189. Lee SY, Hwang DY, Kim YK, Lee JW, Shin IC, Oh KW, Lee MK, Lim JS, Yoon DY, Hwang SJ, Hong JT (2006) PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. FASEB J 20(1):151-153. doi:10.1096/fj.05- 4017fje;1 (Pubitemid 43100497)
190. Smith IF, Green KN, LaFerla FM (2005) Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38(3-4):427-437. doi:10.1016/j.ceca.2005.06.021 (Pubitemid 41283281)
191. Cheung KH, Mei L, Mak DO, Hayashi I, Iwatsubo T, Kang DE, Foskett JK (2010) Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Sci Signal 3(114):ra22. doi:10.1126/scisignal.2000818
192. Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM (2005) Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94(6):1711- 1718. doi:10.1111/j.1471-4159.2005.03332.x
193. Supnet C, Grant J, Kong H, Westaway D, Mayne M (2006) Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J Biol Chem 281(50):38440-38447. doi:10.1074/jbc.M606736200 (Pubitemid 46041967)
194. Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE (2012) Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS One 7(12):e52056. doi:10.1371/journal.pone.0052056
195. Giacomello M, Barbiero L, Zatti G, Squitti R, Binetti G, Pozzan T, Fasolato C, Ghidoni R, Pizzo P (2005) Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis 18(3):638-648. doi:10.1016/j.nbd.2004.10.016 (Pubitemid 40332721)
196. Zatti G, Ghidoni R, Barbiero L, Binetti G, Pozzan T, Fasolato C, Pizzo P (2004) The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores. Neurobiol Dis 15(2):269-278. doi:10.1016/j.nbd.2003.11.002 (Pubitemid 38296758)
197. Zatti G, Burgo A, Giacomello M, Barbiero L, Ghidoni R, Sinigaglia G, Florean C, Bagnoli S, Binetti G, Sorbi S, Pizzo P, Fasolato C (2006) Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 39(6):539-550. doi:10.1016/j.ceca.2006.03.002
198. Hedskog L, Pinho CM, Filadi R, Ronnback A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, Sandebring A, Westerlund M, Graff C, Winblad B, Galter D, Behbahani H, Pizzo P, Glaser E, Ankarcrona M (2013) Modulation of the endoplasmic reticulum- mitochondria interface in Alzheimer's disease and related models. Proc Natl Acad Sci USA 110(19):7916-7921. doi:10.1 073/pnas.1300677110
199. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39(6):889-909
200. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5(6):525-535. doi:10.1016/ S1474-4422(06)70471-9
201. Trinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9(8):445-454. doi:10.1038/nrneu rol.2013.132
202. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58(4):495-505. doi:10.1002/ ana.20624
203. Vives-Bauza C, Przedborski S (2011) Mitophagy: the latest problem for Parkinson's disease. Trends Mol Med 17(3):158-165. doi:10.1016/j.molmed.2010.11. 002
204. Corti O, Brice A (2013) Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr Opin Neurobiol 23(1):100-108. doi:10.1016/j.conb.2012.11.002
205. Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J 31(14):3038- 3062. doi:10.1038/emboj.2012.170
206. McCoy MK, Cookson MR (2012) Mitochondrial quality control and dynamics in Parkinson's disease. Antioxid Redox Signal 16(9):869-882. doi:10.1089/ars.2011. 4074; 10.1089/ars.2011.4019
207. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122(Pt 8):1421-1436 (Pubitemid 29374121)
208. German DC, Manaye KF, Sonsalla PK, Brooks BA (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTPinduced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 648:42-62
209. Nedergaard S, Flatman JA, Engberg I (1993) Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guineapig substantia nigra pars compacta neurones. J Physiol 466:727-747 (Pubitemid 23225251)
210. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62(2):218-229. doi:10.1016/j.neuron.2009.01.033
211. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468(7324):696-700. doi:10.1038/nature09536
212. Surmeier DJ, Schumacker PT (2013) Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease. J Biol Chem 288(15):10736-10741. doi:10.1074/jbc.R112.410530
213. Ottolini D, Cali T, Negro A, Brini M (2013) The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering. Hum Mol Genet 22(11):2152-2168. doi:10.1093/hmg/ddt068
214. Cali T, Ottolini D, Negro A, Brini M (2013) Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics. Biochim Biophys Acta 1832(4):495-508. doi:10.1016/j.bbadis.2013. 01.004
215. Cali T, Ottolini D, Negro A, Brini M (2012) alpha-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum- mitochondria interactions. J Biol Chem 287(22):17914-17929. doi:10.1074/jbc. M111.302794
216. Melachroinou K, Xilouri M, Emmanouilidou E, Masgrau R, Papazafiri P, Stefanis L, Vekrellis K (2013) Deregulation of calcium homeostasis mediates secreted alpha-synuclein-induced neurotoxicity. Neurobiol Aging. doi:10.1016/j.neurobiolag ing.2013.06.006
217. Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung CC, Pearson HA, Boyle JP, Robinson P, Peers C (2009) alpha- Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem 111(5):1192-1201. doi:10.1111/j.1471-4159.2009.06411.x
218. Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N, Itoyama Y, Wang Y, Yao PJ, Bushlin I, Takeda A (2006) Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J Neurochem 97(4):1071-1077. doi:10.1111/j.1471-4159.2006. 03803.x
219. Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E (2009) Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem 108(6):1561-1574. doi:10.1111/j.1471-4159.2009.05932.x
220. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, Abramov AY (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33(5):627-638. doi:10.1016/j.molcel.2009. 02.013
221. Gautier CA, Giaime E, Caballero E, Nunez L, Song Z, Chan D, Villalobos C, Shen J (2012) Regulation of mitochondrial permeability transition pore by PINK1. Mol Neurodegener 7:22. doi:10.1186/1750-1326-7-22
222. Heeman B, Van den Haute C, Aelvoet SA, Valsecchi F, Rodenburg RJ, Reumers V, Debyser Z, Callewaert G, Koopman WJ, Willems PH, Baekelandt V (2011) Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J Cell Sci 124(Pt 7):1115-1125. doi:10.1242/ jcs.078303
223. Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M (1997) Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc Natl Acad Sci USA 94(4):1488-1493 (Pubitemid 27087878)
224. Lledo PM, Somasundaram B, Morton AJ, Emson PC, Mason WT (1992) Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron 9(5):943-954
225. Chard PS, Bleakman D, Christakos S, Fullmer CS, Miller RJ (1993) Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J Physiol 472:341-357 (Pubitemid 24015009)
226. Watase K, Barrett CF, Miyazaki T, Ishiguro T, Ishikawa K, Hu Y, Unno T, Sun Y, Kasai S, Watanabe M, Gomez CM, Mizusawa H, Tsien RW, Zoghbi HY (2008) Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc Natl Acad Sci USA 105(33):11987-11992. doi:10.10 73/pnas.0804350105
227. Chen X, Tang TS, Tu H, Nelson O, Pook M, Hammer R, Nukina N, Bezprozvanny I (2008) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci 28(48):12713-12724. doi:10.1523/JNEUROSCI.3909-08.2008
228. Liu J, Tang TS, Tu H, Nelson O, Herndon E, Huynh DP, Pulst SM, Bezprozvanny I (2009) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci 29(29):9148-9162. doi:10.1523/ JNEUROSCI.0660-09.2009
229. Giacomello M, De Mario A, Primerano S, Brini M, Carafoli E (2012) Hair cells, plasma membrane Ca(2)(+) ATPase and deafness. Int J Biochem Cell Biol 44(5):679-683. doi:10.1016/j.biocel.2012.02.006
230. Empson RM, Turner PR, Nagaraja RY, Beesley PW, Knopfel T (2010) Reduced expression of the Ca(2+) transporter protein PMCA2 slows Ca(2+) dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination. J Physiol 588(Pt 6):907-922. doi:10.1113/jphysiol.2009.182196
231. Empson RM, Akemann W, Knopfel T (2010) The role of the calcium transporter protein plasma membrane calcium ATPase PMCA2 in cerebellar Purkinje neuron function. Funct Neurol 25(3):153-158
232. Fierro L, DiPolo R, Llano I (1998) Intracellular calcium clearance in Purkinje cell somata from rat cerebellar slices. J Physiol 510(Pt 2):499-512 (Pubitemid 28370462)
233. Hartmann J, Konnerth A (2005) Determinants of postsynaptic Ca2+ signaling in Purkinje neurons. Cell Calcium 37(5):459-466. doi:10.1016/j.ceca.2005.01.014 (Pubitemid 40458443)
234. Zhao S, Chen N, Yang Z, Huang L, Zhu Y, Guan S, Chen Q, Wang JH (2008) Ischemia deteriorates the spike encoding of rat cerebellar Purkinje cells by raising intracellular Ca2+. Biochem Biophys Res Commun 366(2):401-407. doi:10.1016/j.bbrc.2007.11.173 (Pubitemid 50010531)
235. Filoteo AG, Elwess NL, Enyedi A, Caride A, Aung HH, Penniston JT (1997) Plasma membrane Ca2+ pump in rat brain. Patterns of alternative splices seen by isoform-specific antibodies. J Biol Chem 272(38):23741-23747 (Pubitemid 27410950)
236. Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365-391. doi:10.1146/annurev-physiol-030212-183717
237. de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM (2009) Molecular genetics of migraine. Hum Genet 126(1):115-132. doi:10.1007/s00439- 009-0684-z
238. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87(3):543-552 (Pubitemid 26374327)
239. Pietrobon D (2013) Calcium channels and migraine. Biochim Biophys Acta 1828(7):1655-1665. doi:10.1016/j.bbamem.2012.11.012
240. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33(2):192-196. doi:10.1038/ng1081 (Pubitemid 36177073)
241. Rose EM, Koo JC, Antflick JE, Ahmed SM, Angers S, Hampson DR (2009) Glutamate transporter coupling to Na, K-ATPase. J Neurosci 29(25):8143-8155. doi:10.1523/JNEUR OSCI.1081-09.2009
242. Tavraz NN, Friedrich T, Durr KL, Koenderink JB, Bamberg E, Freilinger T, Dichgans M (2008) Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2. J Biol Chem 283(45):31097-31106. doi:10.1074/jbc.M802771200
243. Tavraz NN, Durr KL, Koenderink JB, Freilinger T, Bamberg E, Dichgans M, Friedrich T (2009) Impaired plasma membrane targeting or protein stability by certain ATP1A2 mutations identified in sporadic or familial hemiplegic migraine. Channels (Austin) 3(2):82-87
244. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz- Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366(9483):371-377. doi:10.1016/ S0140-6736(05)66786- 4
245. Catterall WA, Kalume F, Oakley JC (2010) NaV1.1 channels and epilepsy. J Physiol 588(Pt 11):1849-1859. doi:10.1113/jph ysiol.2010.187484
246. Cestele S, Scalmani P, Rusconi R, Terragni B, Franceschetti S, Mantegazza M (2008) Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel. J Neurosci 28(29):7273-7283. doi:10.1523/JNEUROSCI.4453-07.2008
247. Kahlig KM, Rhodes TH, Pusch M, Freilinger T, Pereira-Monteiro JM, Ferrari MD, van den Maagdenberg AM, Dichgans M, George AL Jr (2008) Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci USA 105(28):9799-9804. doi:10.1073/pnas.0711717105 (Pubitemid 352031380)